{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:46:01Z","timestamp":1787499961323,"version":"build-2736575974"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Hepatocellular carcinoma (HCC) is an aggressive malignancy with a poor prognosis. Surgical resection is limited. Selective intra-arterial radionuclide therapy (SIRT) emerged as a potential cure for intermediate HCC with portal vein thrombosis. We report a pilot study of a 48-year-old man with recurrent HCC who underwent\n                    <jats:sup>177<\/jats:sup>\n                    Lu-microsphere SIRT (2.2 GBq) in segment III. Posttherapy SPECT\/CT images (24 hours to 3 months) demonstrated excellent localization and prolonged retention within the tumor. Pre- and 3-month post-SIRT CECT showed a notable decrease in arterial enhancement and tumor size. Time-activity curve of the standard and the lesion demonstrated similar decay pattern indicating that\n                    <jats:sup>177<\/jats:sup>\n                    Lu-microspheres act as permanent implant.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000005101","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T15:01:43Z","timestamp":1708441303000},"page":"e170-e171","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["177Lu-Microspheres Selective Intra-arterial Radionuclide Therapy"],"prefix":"10.1097","volume":"49","author":[{"given":"Jaya","family":"Shukla","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sejal","family":"Chopra","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komalpreet","family":"Kaur","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudipta","family":"Chakraborty","sequence":"additional","affiliation":[{"name":"Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Trombay, Mumbai"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harmandeep","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Duseja","sequence":"additional","affiliation":[{"name":"Hepatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Kalra","sequence":"additional","affiliation":[{"name":"Radiodiagnosis, Postgraduate Institute of Medical Education and Research, Chandigarh, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhagwant Rai","family":"Mittal","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,2,6]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2217\/hep.15.6","article-title":"The emerging role of positron emission tomography in hepatocellular carcinoma","volume":"2","year":"2015","journal-title":"Hepat Oncol"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.hpb.2017.04.016","article-title":"Transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis","volume":"19","year":"2017","journal-title":"HPB (Oxford)"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/1435302","article-title":"Transarterial radioembolization (TARE) agents beyond 90 Y-microspheres","volume":"2018","year":"2018","journal-title":"Biomed Res Int"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/MNM.0000000000001225","article-title":"Freeze-dried microspheres for selective intra-arterial radionuclide therapy: an affordable solution","volume":"41","year":"2020","journal-title":"Nucl Med Commun"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1097\/RLU.0000000000002373","article-title":"Two cases of 188Re microspheres for inoperable hepatocellular carcinoma","volume":"44","year":"2019","journal-title":"Clin Nucl Med"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"e312","DOI":"10.1097\/RLU.0000000000002177","article-title":"Demonstration of treatment response to trans-arterial radio-embolization (TARE) on 68Ga-DOTANOC PET\/CT in a patient with metastatic neuroendocrine tumor","volume":"43","year":"2018","journal-title":"Clin Nucl Med"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.ijrobp.2007.05.009","article-title":"Intra-arterial rhenium-188 lipiodol in the treatment of inoperable hepatocellular carcinoma: results of an IAEA sponsored multination study","volume":"69","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s00330-017-4998-2","article-title":"Safety analysis of holmium-166 microsphere scout dose imaging during radioembolisation work-up: a cohort study","volume":"28","year":"2018","journal-title":"Eur Radiol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005101","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T15:06:01Z","timestamp":1750518361000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005101"}},"subtitle":["A Facile and Biocompatible Permanent Micro-Seed Implants for Unresectable Hepatocellular Carcinoma"],"short-title":[],"issued":{"date-parts":[[2024,2,6]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005101","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,6]]}}}